With Debt-Fueled Megafund, MIT Economists Float Idea For Biopharma Woes
This article was originally published in Start Up
Executive Summary
A trio of MIT economists propose a multibillion-dollar biotech fund that deploys asset financing, a lot of leverage, and other financial tricks. It’s a provocative idea, but current biotech investors have their doubts.